DoW Alzheimer’s Transforming Diagnosis Award
Defense Health Agency Contracting Activity - DHACA
Free. Verify your email, then we send one reminder only.
- Posted
- May 1, 2026
- Amount
- $3,200,000
- Closes
- Sep 24, 2026 (in 54 days)
Classification and identifiers
- Solicitation number
- HT942526AZRPTRDA
- Assistance listing (CFDA)
- 12.420
Amount
$3,200,000
Who can apply
About this opportunity
Summary: The fiscal year 2026 (FY26) Alzheimer’s Research Program (AZRP) Transforming Diagnosis Award (TrDA) supports non-incremental, solutions-oriented research that reduces or overcomes important barriers to obtaining a diagnosis, meaningful disease monitoring and accurate prognosis. Distinctive Features: Clinical research is allowed, however clinical trials and animal research are prohibited. Preliminary data are required. Community collaboration is required for studies prospectively enrolling human subjects. Study Population: The AZRP encourages studies to leverage existing cohorts/datasets. Cohorts consisting of individuals 65 years or younger are also encouraged. Career Initiation or Transition (CIT) Partnership Option: The TrDA includes an option for more than one PI and supports b...